Vident Advisory LLC reduced its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 76.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,359 shares of the health services provider's stock after selling 11,046 shares during the period. Vident Advisory LLC's holdings in Maximus were worth $229,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in MMS. Caitong International Asset Management Co. Ltd grew its position in Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after acquiring an additional 526 shares during the period. UMB Bank n.a. raised its stake in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after acquiring an additional 250 shares in the last quarter. GAMMA Investing LLC raised its stake in Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after buying an additional 294 shares in the last quarter. NBC Securities Inc. raised its stake in Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after buying an additional 1,149 shares in the last quarter. Finally, Blue Trust Inc. raised its stake in Maximus by 32.8% in the first quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after buying an additional 303 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Price Performance
Shares of MMS stock traded down $0.48 during midday trading on Monday, reaching $89.06. 51,646 shares of the company traded hands, compared to its average volume of 567,781. The firm's 50 day simple moving average is $79.89 and its two-hundred day simple moving average is $73.20. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The firm has a market cap of $5.02 billion, a PE ratio of 16.41 and a beta of 0.61.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.77. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The company's quarterly revenue was up 2.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Maximus Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Sunday, August 31st. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's dividend payout ratio is 22.10%.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Strong Buy" and an average price target of $90.00.
View Our Latest Research Report on MMS
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.